FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

4400011000001100: Regranex 0.01% gel (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18034701000001114 Regranex 0.01% gel (Janssen-Cilag Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
18034801000001117 Regranex 0.01% gel (Janssen-Cilag Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Regranex 0.01% gel (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Is a Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has active ingredient Becaplermin false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Is a Becaplermin 0.01% gel true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Is a Regranex true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has specific active ingredient Becaplermin true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Regranex 0.01% gel (Janssen-Cilag Ltd) 15 gram Is pack of False Regranex 0.01% gel (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Regranex 0.01% gel (Janssen-Cilag Ltd) 15 gram Has AMP True Regranex 0.01% gel (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start